Headline News about Navient Corp
Navient's Return On Capital Employed Overview
April 28, 2023
Via Benzinga
Analyst Ratings for Navient
April 27, 2023
Via Benzinga
Analyst Expectations for Navient's Future
April 05, 2023
Via Benzinga
Navient: Dividend Insights
February 27, 2023
Via Benzinga
What 4 Analyst Ratings Have To Say About Navient
February 01, 2023
Via Benzinga
Earnings Outlook For Navient
January 23, 2023
Via Benzinga
4 Analysts Have This to Say About Navient
December 01, 2022
Via Benzinga
What To Know About Morgan Stanley's Upgrade of Navient
December 01, 2022
Via Benzinga
Expert Ratings for Navient
December 01, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via Benzinga
Navient Shares Gain Post Q2 Results
July 26, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022
October 07, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
Regeneron Pharmaceuticals To $851? Here Are 5 Other Price Target Changes For Friday
September 09, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.